rain
News

aktualnosci

Zobacz co nowego

EMPLOCITY WITH SECOND PLACE IN A PRESTIGIOUS COMPETITION IN LAS VEGAS

Emplocity took the second place in the so-called “Lightning Competition” taking place in Las Vegas, as part of the largest HR Tech conference – Unleash 2018.

– The fact that we managed to take the second place proves that Polish start-ups count in the global market. Taking part in the competition, we have confirmed the belief that the HR Tech market is the place for a world-class Polish product – says CEO of Emplocity, Krzysztof Sobczak.

More information here.

Congratulations!

INOMATE 100K – ANOTHER PRODUCT DEVELOPED BY BIOAVLEE

Our portfolio company, Bioavlee, is working on a device for automated reductive inoculation.

InoMate 100k is a device for automated reductive inoculation which guarantees the laboratory technician full control over the inoculation process. How can it improve the lab work? Thanks to InoMate 100k we gain acceleration of the process and the reliability of standard inoculation of many samples and also elimination of routine, arduous, manual activities.

 

GENOMTEC AWARDED AT EUROPEAN START-UP DAYS 2018

We are happy to announce that our portfolio company, Genomtec, was awarded in the European Startup Days competition.

Genomtec got the title of the best startup in the Health & Biotechnology category. They jury decided that the mobile smartphone-sized laboratory developed by the Company, which in just 20 minutes is able to identify viruses and bacteria, has the biggest business potential among other biotechnology projects and deserves to be honored with the prize.

Congratulations to the entire Genomtec team!

ABOUT BIOAVLEE IN THE BUSINESS ZONE OF GAZETA WROCŁAWSKA

In the “Business Zone”, an appendix to Gazeta Wrocławska, an interesting article about Bioavlee was published. We encourage you to read.

– Cosmetic or food products before being placed on the market are evaluated in terms of the safety of their use. Our solution allows to assess the product’s safety by obtaining a “fingerprint” of the examined microorganisms thanks to the diffraction of light on the colonies of microorganisms. We used the patent in the proprietary Avlee 650 system – says Michał Wronecki, president of Bioavlee.

XTPL AT GLOBAL VENTURE FORUM

Global Venture Forum offers an environment for corporates, top CXOs and investors to share insights into industry trends and paths to cooperation in AI, Blockchain, Cloud and Industry 4.0. XTPL was invited to pitch at the event as one of only 25 other young companies from all over the World. The company presented its technology to the major players in the industry on 11th of May. Congrats!

PULS BIZNESU ABOUT ADVANCED PROTECTION SYSTEMS

We encourage you to read a highly interesting article about Advanced Protection Systems in Puls Biznesu.

“In recent years, we have spent hundreds of millions of dollars on higher fences and safeguards that reduce smuggling to prisons, but we find record-breaking quantities of weapons and drugs at convicts, and it turns out that the spade work is being done by drones” – observed one of the heads of the US federal prison service and appealed for technological support.

OUR NEW INVESTMENT: BIOCELTIX

We are pleased to inform you about our new investment: Bioceltix.
Bioceltix Sp. z o. o. develops innovative biological drugs based on stem cells, intended for companion animals. According to forecasts, by 2020 the share of biological medicines in the entire pharmaceutical market will increase up to 28%. This means USD 390 billion for biological therapies.

Strategic activities of Bioceltix include the organization of the cGMP plant based on an isolated line for the production of veterinary biological drugs based on stem cells in a pharmaceutical standard. The company conducts an individual dialogue with the European Medicines Agency as part of the scientific advice procedure – the purpose of the talks is to approve the full registration path of the first BCX-CM-J drug.

More information at http://bioceltix.com/o-firmie/

The investment is carried out by Leonarto Alfa, in cooperation with the National Center for Research and Development under the framework of the Bridge Alpha program.

FORMER PRESIDENT AND CO-FOUNDER OF THE WSE JOINS THE SUPERVISORY BOARD OF XTPL

We are pleased to announce that the former president and co-founder of Giełda Papierw Wartościowych (the Warsaw Stock Exchange), Wiesław Rozłucki, has been appointed to the Supervisory Board of XTPL SA. He will actively support the Company’s capital market activities and its general corporate governance.

“Innovative tech companies are exactly what is needed to secure the future and continued success of the Warsaw Stock Exchange. Im impressed by the fact that the present-day Polish tech industry refuses to consider itself a second-rate player, and is boldly aiming directly for the global markets”, says Wiesław Rozłucki, former president and co-founder of Warsaw Stock Exchange, who joins XTPLs Supervisory Board.

http://www.parkiet.com/Technologie-i-IT/304179951-Wieslaw-Rozlucki-w-nadzorze-XTPL.html

 

ADVANCED PROTECTION SYSTEMS AT ISC WEST 2018 IN LAS VEGAS

Ctrl+Sky counter UAV system developed by our portfolio company Advanced Protection Systems, was presented at the ISC West 2018 in Las Vegas.
4 different detection sensors integrated with 2 layer neutralization scheme provide for a dome like protection without blind zones. Ctrl+Sky is based on proprietary technologies featuring modular and scalable design as well as web-based CyView software for ease of use.

PULS BIZNESU ABOUT OUR INVESTMENT ACTIVITY

Puls Biznesu published today an extensive article about our investment activity. We encourage you to read.

“We focus on investments in new technologies and we still have capacity for 4 new investments this year. We invest in broadly understood biotechnology, including molecular biology, nanotechnology, medical devices and space technologies. There are many fashionable words, including “blockchain”, which most of the market unfortunately does not understand. We do not rush in favor of fashion, but rather find in Poland scientists with a business spirit who have an idea for solving a specific problem and need support in transforming the idea into a real, profitable business “– says Konrad Pankiewicz.

https://www.pb.pl/leonarto-wrzuci-portfel-na-parkiet-909999

 

XTPL S.A. PUBLISHES ANNUAL REPORT

Filip Granek in his message for the Shareholders of XTPL S.A.:

“XTPL has been designed to provide the unique knowledge and technology sought by the world’s biggest industrial companies. Technological barriers are meant to be broken. This is why we are finishing our preparations to launch the production of laboratory printers. Conductive lines printed with the use of the patented XTPL method reach the parameters smaller than 100 nm. These are unparalleled results that cannot be replicated by any other printing method in the world.”

GENOMTEC AND AMPLUS BRING GENOMTEC FRESH TO THE MARKET

portalspożywczy.pl informs about a joint project of Genomtec and Amplus.
The project concerns the launch of Genomtec Fresh, a mobile diagnostic device for the detection of fungi, nematodes and bacteria in the cultivation of fruit and vegetables.

“Thanks to Genomtec Fresh, it can be examined quickly and with 100% certainty whether there are no fungi, nematodes or bacteria threatening crops in the soil. Early diagnosis means not only a significant reduction in crop losses, but also much more rational use of plant protection products”– emphasizes Miron Tokarski, CEO of Genomtec.

Congratulations!

http://m.portalspozywczy.pl/technologie/wiadomosci/genomtec-i-amplus-wprowadzaja-na-rynek-innowacyjne-rozwiazanie-dla-sadownictwa-i-rolnictwa,156742.html

EMPLOCITY CHATBOT RECRUITES EMPLOYEES FOR BUDIMEX

Puls Biznesu reports on the cooperation of Emplocity with Budimex S.A., one of the largest construction groups in Poland.

“With such a large scale of recruitment and a competitive market, we want to focus on innovative solutions. A modern company is one that is where its candidates for employment are, and today everyone is on Facebook. Therefore, Chatbot fits well in the digital transformation strategy that we are currently implementing “– notes Cezary Mączka, a member of the Budimex management board, director of the human resource management department, quoted in the company’s communication.

The Budimex Group employs almost 5,000 people and cooperates annually with 12,000 contractors implementing over 100 contracts during the year.

Congratulations to the Emplocity team!

https://www.pb.pl/chatbot-szuka-1000-pracownikow-dla-budimexu-908289 

NESTMEDIC WITH PREGNABIT AT MEDICAL FAIR INDIA IN MUMBAI

Last weekend, the Nestmedic team presented its teleKTG solution during fairs, both in Poland and abroad. Thanks to the PARP grant, the company had the opportunity to show the Pregnabit system at the international Medical Fair India event in Mumbai, and on March 15-17 at SALMED at the Poznań International Fair.

During both events, Nestmedic technology enjoyed great interest.

The Indian medical device market, which has been estimated at around USD 8 billion, is one of the places where, according to our development strategy, we see the potential for introducing our teleKTG. The figures speak for themselves: currently, health care spending is slightly more than USD 160 billion in this country, and by 2020 a further increase to almost 300 billion is expected. Of course, it will be necessary to develop an appropriate cooperation model especially for countries like India, but we are prepared for it. Thanks to the fair in Mumbai, we established a number of contacts, we also started the first business talks, which will be continued – says Dr. med. Patrycja Wizińska-Socha, President of Nestmedic.

Also the team of Nestmedic considered the 27th edition of the International Trade Fair of Medical Equipment and Equipment SALMED 2018 to be very successful. In Poznań, the company had another opportunity to present the Pregnabit system, exchange experiences and meet directly with specialists and representatives of the medical industry.

EMPLOCITY INTRODUCES AI TO THE WORLD OF RECRUITMENT

We are pleased to present our new investment – Emplocity.

The founders of Emplocity are Arkadiusz Talun and Krzysztof Sobczak. The company operates in the area of AI / NLP, chatbots and advanced data processing, supporting HR departments in the recruitment process, in particular in the acquisition of candidates (also passive), pre-selection and communication with candidates.

Emplocity is the author of the world’s first bot, which introduces a unique process innovation, becoming the candidate in the recruitment process. The company is a laureate of the ABSL Start-Up Challenge and the winner of the Eagle of Innovation Startup 2017 competition, organized by the editorial staff of “Rzeczpospolita”.

The investment is carried out in cooperation with the National Center for Research and Development under the Bridge Alfa program.

DR. FILIP GRANEK ABOUT XTPL PLANS IN PARKIET TV

Dr inż. Filip Granek was a guest of Dariusz Wieczorek in Parkiet TV.

“If a company from Silicon Valley, from Cupertino, knocks on our door, it shows that the technology we have has a lot of potential. This gives us confidence and confidence in planning the next steps of our international expansion.”

NESTMEDIC LAUNCHES A PILOT WITH MEDICOVER

Nestmedic S.A. successfully completed negotiations with one of the leaders in the private healthcare market. The mobile Pregnabit system will be tested in the network of Medicover Poland medical facilities. The current implementation is to be an introduction to further cooperation with international medical networks.
Congratulations!

http://www.parkiet.com/Medycyna-i-zdrowie/303159996-Nestmedic-Umowa-pilotazowa-z-Medicoverem.html

 

XTPL: BREAKTHROUGH CLOSER THAN BY A HAIR’S BREADTH

We encourage you to read a very interesting interview with Filip Granek, the CEO of XTPL.

“We make it possible to leapfrog the precision of printing materials not by several percent, but by multiple times. No existing method could provide this so far”- says Filip Granek, CEO of XTPL, in an interview with WNP.PL.

http://www.wnp.pl/tech/xtpl-nanotechnologia-przelom-jest-blizej-niz-o-wlos,318272_1_0_0.html

XTPL IN INWESTORZY.TV

We invite you to watch the interview with Dr. Filip Granek (CEO of XTPL), who was a guest of Agnieszka Zaręba in inwestorzy.tv.

XTPL, developing a breakthrough technology for printing nanomaterials, has just started preparations to enter the main floor of the WSE and the Open Market in Frankfurt.
Interestingly, the company only recently debuted on NewConnect.

MONEY.PL ABOUT GENOMTEC

“A breakthrough invention of Wroclaw scientists will cause that the laboratory detecting dangerous bacteria and viruses will decrease to the size … of smartphone.

What drew the attention of the prosecutor in charge of a murder case is the fact that oak leaves were found in the pocket of the dead man’s coat. The body, however, was found under a different species of tree. This is were the scientists came to action. ”

https://www.money.pl/gospodarka/wiadomosci/artykul/mlodzi-polacy-szykuja-rewolucje-w-medycynie,26,0,2398234.html

XTPL: DEBUT ON THE MAIN MARKET IN A FEW MONTHS

Our portfolio company, XTPL, which develops the technology of ultra-precise printing of nanomaterials, intends to transfer quotations to the main market of the Warsaw Stock Exchange soon.

“The debutant from September, developing the technology of ultra-precise printing of nanomaterials, intends to transfer quotations to the main market. Next plans assume the introduction of the action also on the Frankfurt Open Market, operating at Deutsche Boerse.”

http://www.parkiet.com/Technologie-i-IT/312139977-XTPL-Debiut-na-glownym-rynku-w-kilka-miesiecy.html&template=restricted

APS PROTECTS AGAINST DRONES. “PULS BIZNESU” ABOUT OUR PORTFOLIO COMPANY!

The Polish company wants to conquer the US and Canadian markets. It will also open a company in Saudi Arabia to defend sheiks and refiners against terrorism.USD 16 billion – such will be the demand for drone detection and neutralization systems in 2022 – according to Markets and Markets. Still in 2016, it was close to zero. “The dynamic growth of this value is the result of the growing popularity and demand for unmanned aircraft. With the increase in their sales, the demand for antidrone systems is also growing – says Radosław Piesiewicz, president of Advanced Protection Systems (APS).

https://www.pb.pl/aps-ochroni-przed-dronami-904962

OUR NEW INVESTMENT: GENOMTEC

 

This determined, young man on the picture is Miron Tokarski – co-founder and main commander of the Genomtec company. Miron is a laboratory diagnostician, graduate of the Pharmaceutical Faculty with the Department of Medical Analytics at the Medical University of Wroclaw, PhD student in the field of molecular biology. Author of the publications and co-author of the Genomtec patents. Head of a research project of the National Science Center.

Genomtec is working on a handheld (portable) diagnostic device, based on the amplification and detection of specific DNA and RNA fragments – the “golden standard” of molecular diagnostics. The device can be used for examinations performed on humans, animals as well as in agriculture, the food industry and in the control of environmental contamination.

NANOPARTICLES DANCE TO THEIR TUNE. ABOUT XTPL IN WYBORCZA.PL

(…) the head spills a thin stream of mascara with nanoparticles of metals, e.g. silver, on the surface of glass or foil. Then we subject them to the action of an external electric field, thanks to which nanoparticles combine to form ultra-thin lines – wires of the size of billions of parts of the meter. What’s more, they are transparent and conduct electricity – says Maciej Adamczyk from the management of XTPL.

http://wyborcza.pl/7,155068,22957092,nanoczasteczki-tancza-tak-jak-im-zagraja.html

NESTMEDIC IS COMING TO SCANDINAVIA

The Pregnabit system will be tested by the Norwegian leader of telemedicine solutions providers. This is the beginning of the commercialization of the company solutions in northern Europe.

Nestmedic has just signed the first cooperation agreement in Scandinavia. As part of it, the Norwegian partner – a telemedicine company Dignio AS Aksjeselskap – will test the Pregnabit device for a mobile KTG study, as well as a platform for presenting and analyzing telekCT records dedicated to the system.
Norway is the fourth country in the world in terms of the amount of funds spent on healts per capita (6.7 thousand USD per person, according to OECD Health Statistics 2017). This is also one of the strategic markets for Nestmedic.

– Nestmedic’s foreign expansion is gaining momentum. We have recently announced cooperation with a partner in Germany, now Norway is starting. It is a country with high spending on telemedicine and – on a European scale – high fertility – says PhD Patrycja Wizińska-Socha, President of the Management Board of Nestmedic.

Contact us